tiprankstipranks
Advertisement
Advertisement

ZYME Stock Latest News

Zymeworks authorizes share repurchase program of up to $125M
The FlyZymeworks authorizes share repurchase program of up to $125M
2d ago
ZYME
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
PremiumCompany Announcements
Zymeworks Authorizes 2026 Share Repurchase Program, Affirms Liquidity
2d ago
8K
ZYME
Zymeworks Maintained at Buy as Analyst Highlights Cash Runway, Upcoming Catalysts and Reiterates $46 Price Target
PremiumRatings
Zymeworks Maintained at Buy as Analyst Highlights Cash Runway, Upcoming Catalysts and Reiterates $46 Price Target
6d ago
ZYME
Zymeworks’ Earnings Call Balances Progress And Pressure
PremiumCompany Announcements
Zymeworks’ Earnings Call Balances Progress And Pressure
8d ago
ZYME
Zymeworks: Strong Ziihera Royalty Momentum and Deep Oncology Pipeline Underpin Buy Rating and Favorable Risk-Reward
PremiumRatings
Zymeworks: Strong Ziihera Royalty Momentum and Deep Oncology Pipeline Underpin Buy Rating and Favorable Risk-Reward
9d ago
ZYME
Zymeworks reports Q1 EPS (59c), consensus (10c)
PremiumThe FlyZymeworks reports Q1 EPS (59c), consensus (10c)
9d ago
ZYME
Zymeworks Reports Q1 2026 Results and Pipeline Progress
Premium
Company Announcements
Zymeworks Reports Q1 2026 Results and Pipeline Progress
9d ago
8K
ZYME
Zymeworks: Buy Rating Reiterated as Priority Review for Zanidatamab Supports Upside; $46 Price Target Maintained
Premium
Ratings
Zymeworks: Buy Rating Reiterated as Priority Review for Zanidatamab Supports Upside; $46 Price Target Maintained
19d ago
ZYME
Zymeworks: Buy Rating Reaffirmed on Zanidatamab Momentum and Royalty-Focused Model; $34 Price Target Maintained
PremiumRatings
Zymeworks: Buy Rating Reaffirmed on Zanidatamab Momentum and Royalty-Focused Model; $34 Price Target Maintained
19d ago
ZYME
Zymeworks reports results from dose-escalation part of Phase 1 study for ZW191
PremiumThe Fly
Zymeworks reports results from dose-escalation part of Phase 1 study for ZW191
25d ago
ZYME
Zymeworks Sets May 7 Date to Unveil Q1 2026 Results and Pipeline Update
PremiumCompany Announcements
Zymeworks Sets May 7 Date to Unveil Q1 2026 Results and Pipeline Update
1M ago
ZYME
Zymeworks Bolsters Executive Team to Drive Next Phase of Growth
PremiumCompany Announcements
Zymeworks Bolsters Executive Team to Drive Next Phase of Growth
1M ago
ZYME
Zymeworks appoints new Head of R&D and Chief Business Officer
PremiumThe FlyZymeworks appoints new Head of R&D and Chief Business Officer
1M ago
ZYME
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
Premium
The Fly
Leerink says Tubulis deal highlights value of ADC platforms like Sutro’s
1M ago
GILD
IMNM
Zymeworks Names Kristin Stafford as New Chief Financial Officer
Premium
Company Announcements
Zymeworks Names Kristin Stafford as New Chief Financial Officer
2M ago
ZYME
Zymeworks appoints Kristin Stafford as CFO
PremiumThe Fly
Zymeworks appoints Kristin Stafford as CFO
2M ago
NVCR
ZYME
Zymeworks (ZYME): Advancing ADC Platform, Fast-Track ZW191, and Broad FRα Opportunity Support Buy Rating
PremiumRatings
Zymeworks (ZYME): Advancing ADC Platform, Fast-Track ZW191, and Broad FRα Opportunity Support Buy Rating
2M ago
ZYME
Zymeworks Wins FDA Fast Track Status for Ovarian Cancer Drug ZW191
PremiumCompany Announcements
Zymeworks Wins FDA Fast Track Status for Ovarian Cancer Drug ZW191
2M ago
ZYME
Zymeworks receives FDA Fast Track Designation for ZW191
PremiumThe Fly
Zymeworks receives FDA Fast Track Designation for ZW191
2M ago
ZYME
Zymeworks announces Fast Track designation for ZW191 by FDA
PremiumThe FlyZymeworks announces Fast Track designation for ZW191 by FDA
2M ago
ZYME
Zymeworks to Highlight Pipeline and Asset Strategy at Key Investor Conferences
Premium
Company Announcements
Zymeworks to Highlight Pipeline and Asset Strategy at Key Investor Conferences
2M ago
ZYME
Zymeworks Highlights New Ziihera Data to Broaden HER2 Cancer Reach
Premium
Company Announcements
Zymeworks Highlights New Ziihera Data to Broaden HER2 Cancer Reach
2M ago
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >